Obstetrics and Gynecology International / 2012 / Article / Tab 3

Clinical Study

Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas

Table 3

Clinical outcomes of UAE in patients with uterine leiomyomas ( ).

Improvement of symptoms and/or reduction in the leiomyoma size 24
Reduction in the leiomyoma volume at 6 months after UAE ( )67.9 ± 16.3% ( )
Removal of submucosal leiomyoma8
Improvement of anemia
 Hemoglobin value at 2 months after UAE (g/dL)    8.5 ± 3.0 →11.5 ± 1.5 ( )
Prognosis 
 No effect 1  
 Hysterectomy 3
 Recurrence6
Complications 
 Abdominal pain, nausea, and fever     all the patients, short term 
 Elevated liver enzymes1
 Leg pain 1
 Menopause none

Mean ± standard deviation.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.